Results 81 to 90 of about 34,696 (251)
c‐Met‐Targeted Imaging Agents: Progress and Challenges
This review summarizes recent advances in c‐Met‐targeted imaging probes, including hepatocyte growth factor (HGF) ligands, antibodies, peptides, and small molecules across magnetic resonance imaging (MRI), positron emission tomography (PET), single‐photon emission computed tomography (SPECT), and optical imaging modalities.
Yonghao Li +4 more
wiley +1 more source
INTRODUCTION. Currently in the Russian Federation and the Eurasian Economic Union (EAEU), the conduct of non-clinical studies of radiopharmaceuticals is regulated by general guidelines on non-clinical studies, which are applicable to multiple groups of ...
O. E. Klementyeva +5 more
doaj +1 more source
Occupational burnout is associated with negative feelings about the workplace and is often caused by a high workload and a non‐supportive workplace. It is associated with absenteeism, high turnover of staff and decreased patient care. More than half of the New Zealand participants and three quarters of the Australian participants had moderate levels of
Melissa Shields +2 more
wiley +1 more source
Research Progress of 64Cu-Radiopharmaceuticals in Clinical Trial for Tumor Diagnosis
Positron computed emission tomography (PET) is an important diagnosis and imaging tool for nuclear medicine with the advantages of high sensitivity, resolution, and safety.
ZHAO Hailong;LI Hongyu
doaj
Molecular theranostics: principles, challenges and controversies
Molecular theranostics offers a powerful tool to drive precision medicine in nuclear oncology. While theranostics is not a new principle in nuclear medicine, recent advances in instrumentation and radiopharmacy have driven a reinvigoration and a broader suite of applications.
Geoffrey Currie
wiley +1 more source
Technetium-99m (99mTc) is currently available from 99Mo/99mTc generators as the β-decay product of 99Mo (T1⁄2=66 h). Nowadays, 99Mo is mostly obtained as a fission product in nuclear reactors by neutron-induced reactions on highly enriched uranium ...
Bello, Michele +17 more
core
Radiopharmaceutical small-scale preparation in Europe: will we be able to harmonize the situation?
Background Radiopharmaceuticals have been considered a special group of medicines in Europe since 1989. The use of radiopharmaceuticals that have marketing authorization should always be the first option in clinical use, however due to their special ...
Estrella Moya +3 more
doaj +1 more source
Abstract Background Visuospatial deficits in Parkinson's disease (PD) often precede dementia and complicate daily functioning. Alzheimer's disease (AD) pathology and α‐synuclein aggregation frequently co‐occur in PD, but their combined impact on cognition is unclear.
David Ledingham +8 more
wiley +1 more source
Radiopharmaceuticals for Diagnostics in Nuclear Medicine [PDF]
Bakalářská práce na téma Radiofarmaka pro diagnostiku v nukleární medicíně je rozdělena na dvě hlavní části. V první části jsem zpracoval teoretické informace o nukleární medicíně, radiofarmakách, radiační ochraně.
Vít Lajner
core

